Literature DB >> 15604526

Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population.

Francisco J Tinahones1, Juan Miguel Gómez-Zumaquero, Lourdes Garrido-Sánchez, Eduardo García-Fuentes, Gemma Rojo-Martínez, Isabel Esteva, Maria Soledad Ruiz de Adana, Fernando Cardona, Federico Soriguer.   

Abstract

Most studies of antibodies to oxidized LDL have been undertaken in patients with different diseases and cardiovascular risk factors. However, very few studies have researched the distribution and determining factors of antibodies to oxidized LDL in the general population. A total of 1,354 persons (817 females and 537 males) aged 5-65 years were included in this study. They were selected randomly from the population census of Málaga, in southern Spain. The females had lower levels of total cholesterol and triglycerides and higher levels of HDL-cholesterol and a very significant increase (P < 0.0001) in levels of anti-oxidized LDL [low density lipoprotein modified by malondialdehyde (MDA-LDL)] antibodies but no difference in levels of immune complexes consisting of LDL and IgG antibodies (anti-LDL immune complex). Younger persons (16-35 years) had higher levels of anti-oxidized LDL (MDA-LDL) antibodies than persons older than 35 years (P = 0.05). Levels of immune complexes were significantly higher (P = 0.05) in persons aged 5-15 years than in persons older than 40 years. A very weak association was found between levels of anti-oxidized LDL (MDA-LDL) antibodies and anti-LDL immune complexes. The higher prevalence of anti-oxidized LDL (MDA-LDL) antibodies in females and young persons is in agreement with studies that found an inverse association between atherosclerosis and the level of these antibodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604526     DOI: 10.1194/jlr.M400290-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study.

Authors:  Qi Chen; Steven E Reis; Candace Kammerer; Wendy Craig; Dennis M McNamara; Richard Holubkov; Barry L Sharaf; George Sopko; Daniel F Pauly; C Noel Bairey Merz; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

2.  Reduced Atherosclerosis in apoE-inhibitory FcγRIIb-Deficient Mice Is Associated With Increased Anti-Inflammatory Responses by T Cells and Macrophages.

Authors:  Hang Pong Ng; Xinmei Zhu; Erin Y Harmon; Michelle R Lennartz; Shanmugam Nagarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-19       Impact factor: 8.311

3.  Soy isoflavones reduce electronegative low-density lipoprotein (LDL(-)) and anti-LDL (-) autoantibodies in experimental atherosclerosis.

Authors:  Nágila Raquel Teixeira Damasceno; Elaine Apolinário; Fabiana Dias Flauzino; Irene Fernandes; Dulcineia Saes Parra Abdalla
Journal:  Eur J Nutr       Date:  2007-01-30       Impact factor: 5.614

4.  Lipid profiles and oxidative stress parameters in male and female hemodialysis patients.

Authors:  A Osorio; E Ortega; T de Haro; J M Torres; P Sánchez; E Ruiz-Requena
Journal:  Mol Cell Biochem       Date:  2011-03-09       Impact factor: 3.396

5.  Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein.

Authors:  Nurcan Cengiz; Esra Baskin; Nurzen Sezgin; Pinar Agras; Mehmet Haberal
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

6.  Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.

Authors:  E F H van Bommel; L J H van Tits; E A van den Berg; J Prins; A F H Stalenhoef
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

7.  Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins.

Authors:  M C Slot; R Theunissen; P van Paassen; J G M C Damoiseaux; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

8.  Associations between oxidized LDL to LDL ratio, HDL and vascular calcification in the feet of hemodialysis patients.

Authors:  Won Suk An; Seong-Eun Kim; Ki-Hyun Kim; Hae-Rahn Bae; Seo-Hee Rha
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

9.  Antioxidized LDL antibodies are associated with different metabolic pathways in patients with atherosclerotic plaque and type 2 diabetes.

Authors:  M Rosa Bernal-Lopez; Lourdes Garrido-Sanchez; Victor Gomez-Carrillo; Jose Luis Gallego-Perales; Vicenta Llorente-Cortes; Fernando Calleja; Ricardo Gomez-Huelgas; Lina Badimon; Francisco J Tinahones
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

10.  Improved carbohydrate metabolism after bariatric surgery raises antioxidized LDL antibody levels in morbidly obese patients.

Authors:  Lourdes Garrido-Sánchez; Jose M García-Almeida; Sara García-Serrano; Isabel Cardona; Juan García-Arnes; Federico Soriguer; Francisco J Tinahones; Eduardo García-Fuentes
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.